New

Angiotensin Converting Enzyme Inhibitors Market

2021

Angiotensin Converting Enzyme Inhibitors Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (E1 Ubiquitin Activating Enzyme, E2 Ubiquitin Crosslinking Enzyme, and E3 Ubiquitin Ligase); End Use (Cancer, Biological Engineering, Gastroenterology, and Others), and Geography

| Report Code: TIPRE00023189 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Angiotensin Converting Enzyme Inhibitors Market 2028 By Type, End Use, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Angiotensin converting enzyme inhibitors are a class of drugs used to treat heart failure, high blood pressure (hypertension), or lower complications of myocardial infarction (heart attack). These drugs are also helpful in lowering kidney disorders progression in patients with chronic kidney disease or kidney disease in diabetic patients. The process of angiotensin converting enzyme inhibitors is to reduce the amount of angiotensin II produced. Angiotensin II affects the body to increase pressure in the kidney, blood volume, and blood pressure. Angiotensin converting enzyme inhibitors open the blood vessels by lowering the amount of angiotensin II in the body. These also raise the amount of urine produced by kidneys. This results in reducing pressure in the kidney, lowering blood volume, and blood pressure.

MARKET SCOPE

The "Global Angiotensin Converting Enzyme Inhibitors Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Angiotensin converting enzyme inhibitors market with detailed market segmentation by drugs, application, distribution channel, and geography. The report provides key statistics on the market status of the leading Angiotensin converting enzyme inhibitors market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on drugs, the global Angiotensin converting enzyme inhibitors market is segmented into benazepril, perindopril, trandfolapril, captopril, enalapril, lisinopril, ramipril, others.
  •  On the basis of application, the market is segmented into hypertension, coronary artery disease, heart failure, chronic kidney disease, scleroderma, migraine, others.
  •  On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, others.

MARKET DYNAMICS
Drivers

  •   Increase in the blood pressure.
  •   Rise in the cases of heart failure.
  •   Rise in product launches for ACE inhibitor drug class.

Restraints

  •   The insufficient power supply is the major restraining factor for the Microelectronic implants and the high cost of these products.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Angiotensin converting enzyme inhibitors market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Angiotensin converting enzyme inhibitors market in these regions.

IMPACT OF COVID-19 ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Angiotensin converting enzyme inhibitors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Angiotensin converting enzyme inhibitors market are anticipated to lucrative growth opportunities in the future with the rising demand for Angiotensin converting enzyme inhibitors in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Angiotensin converting enzyme inhibitors market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Pfizer, Inc.
  •  AstraZeneca Pharmaceutical Company
  •  Novartis AG
  •  Daiichi Sankyo Company, Ltd.
  •  United Therapeutics Corporation
  •  Sanofi S.A.
  •  Johnson & Johnson Services, Inc.
  •  Merck KGaA
  •  Takeda Pharmaceutical Company
  •  Bayer AG

The Insight Partner's dediAngiotensin converting enzyme inhibitorsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Angiotensin Converting Enzyme Inhibitors Market - By Drugs
1.3.2 Angiotensin Converting Enzyme Inhibitors Market - By Application
1.3.3 Angiotensin Converting Enzyme Inhibitors Market - By Distribution Channel
1.3.4 Angiotensin Converting Enzyme Inhibitors Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANGIOTENSIN CONVERTING ENZYME INHIBITORS - GLOBAL MARKET OVERVIEW
6.2. ANGIOTENSIN CONVERTING ENZYME INHIBITORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. BENAZEPRIL
7.3.1. Overview
7.3.2. Benazepril Market Forecast and Analysis
7.4. PERINDOPRIL
7.4.1. Overview
7.4.2. Perindopril Market Forecast and Analysis
7.5. TRANDFOLAPRIL
7.5.1. Overview
7.5.2. Trandfolapril Market Forecast and Analysis
7.6. CAPTOPRIL
7.6.1. Overview
7.6.2. Captopril Market Forecast and Analysis
7.7. ENALAPRIL
7.7.1. Overview
7.7.2. Enalapril Market Forecast and Analysis
7.8. LISINOPRIL
7.8.1. Overview
7.8.2. Lisinopril Market Forecast and Analysis
7.9. RAMIPRIL
7.9.1. Overview
7.9.2. Ramipril Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis
8. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HYPERTENSION
8.3.1. Overview
8.3.2. Hypertension Market Forecast and Analysis
8.4. CORONARY ARTERY DISEASE
8.4.1. Overview
8.4.2. Coronary Artery Disease Market Forecast and Analysis
8.5. HEART FAILURE
8.5.1. Overview
8.5.2. Heart Failure Market Forecast and Analysis
8.6. CHRONIC KIDNEY DISEASE
8.6.1. Overview
8.6.2. Chronic Kidney Disease Market Forecast and Analysis
8.7. SCLERODERMA
8.7.1. Overview
8.7.2. Scleroderma Market Forecast and Analysis
8.8. MIGRAINE
8.8.1. Overview
8.8.2. Migraine Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Angiotensin Converting Enzyme Inhibitors Market Overview
10.1.2 North America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis
10.1.3 North America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Drugs
10.1.4 North America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Application
10.1.5 North America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Countries
10.1.6.1 United States Angiotensin Converting Enzyme Inhibitors Market
10.1.6.1.1 United States Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.1.6.1.2 United States Angiotensin Converting Enzyme Inhibitors Market by Application
10.1.6.1.3 United States Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.1.6.2 Canada Angiotensin Converting Enzyme Inhibitors Market
10.1.6.2.1 Canada Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.1.6.2.2 Canada Angiotensin Converting Enzyme Inhibitors Market by Application
10.1.6.2.3 Canada Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.1.6.3 Mexico Angiotensin Converting Enzyme Inhibitors Market
10.1.6.3.1 Mexico Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.1.6.3.2 Mexico Angiotensin Converting Enzyme Inhibitors Market by Application
10.1.6.3.3 Mexico Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Angiotensin Converting Enzyme Inhibitors Market Overview
10.2.2 Europe Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis
10.2.3 Europe Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Drugs
10.2.4 Europe Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Application
10.2.5 Europe Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Angiotensin Converting Enzyme Inhibitors Market
10.2.6.1.1 Germany Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.2.6.1.2 Germany Angiotensin Converting Enzyme Inhibitors Market by Application
10.2.6.1.3 Germany Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.2.6.2 France Angiotensin Converting Enzyme Inhibitors Market
10.2.6.2.1 France Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.2.6.2.2 France Angiotensin Converting Enzyme Inhibitors Market by Application
10.2.6.2.3 France Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.2.6.3 Italy Angiotensin Converting Enzyme Inhibitors Market
10.2.6.3.1 Italy Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.2.6.3.2 Italy Angiotensin Converting Enzyme Inhibitors Market by Application
10.2.6.3.3 Italy Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.2.6.4 Spain Angiotensin Converting Enzyme Inhibitors Market
10.2.6.4.1 Spain Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.2.6.4.2 Spain Angiotensin Converting Enzyme Inhibitors Market by Application
10.2.6.4.3 Spain Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.2.6.5 United Kingdom Angiotensin Converting Enzyme Inhibitors Market
10.2.6.5.1 United Kingdom Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.2.6.5.2 United Kingdom Angiotensin Converting Enzyme Inhibitors Market by Application
10.2.6.5.3 United Kingdom Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.2.6.6 Russia Angiotensin Converting Enzyme Inhibitors Market
10.2.6.6.1 Russia Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.2.6.6.2 Russia Angiotensin Converting Enzyme Inhibitors Market by Application
10.2.6.6.3 Russia Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.2.6.7 Rest of Europe Angiotensin Converting Enzyme Inhibitors Market
10.2.6.7.1 Rest of Europe Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.2.6.7.2 Rest of Europe Angiotensin Converting Enzyme Inhibitors Market by Application
10.2.6.7.3 Rest of Europe Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Overview
10.3.2 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis
10.3.3 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Drugs
10.3.4 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Angiotensin Converting Enzyme Inhibitors Market
10.3.6.1.1 Australia Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.3.6.1.2 Australia Angiotensin Converting Enzyme Inhibitors Market by Application
10.3.6.1.3 Australia Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.3.6.2 China Angiotensin Converting Enzyme Inhibitors Market
10.3.6.2.1 China Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.3.6.2.2 China Angiotensin Converting Enzyme Inhibitors Market by Application
10.3.6.2.3 China Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.3.6.3 India Angiotensin Converting Enzyme Inhibitors Market
10.3.6.3.1 India Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.3.6.3.2 India Angiotensin Converting Enzyme Inhibitors Market by Application
10.3.6.3.3 India Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.3.6.4 Japan Angiotensin Converting Enzyme Inhibitors Market
10.3.6.4.1 Japan Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.3.6.4.2 Japan Angiotensin Converting Enzyme Inhibitors Market by Application
10.3.6.4.3 Japan Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.3.6.5 South Korea Angiotensin Converting Enzyme Inhibitors Market
10.3.6.5.1 South Korea Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.3.6.5.2 South Korea Angiotensin Converting Enzyme Inhibitors Market by Application
10.3.6.5.3 South Korea Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market
10.3.6.6.1 Rest of Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.3.6.6.2 Rest of Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market by Application
10.3.6.6.3 Rest of Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market Overview
10.4.2 Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis
10.4.3 Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Drugs
10.4.4 Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Angiotensin Converting Enzyme Inhibitors Market
10.4.6.1.1 South Africa Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.4.6.1.2 South Africa Angiotensin Converting Enzyme Inhibitors Market by Application
10.4.6.1.3 South Africa Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.4.6.2 Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market
10.4.6.2.1 Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.4.6.2.2 Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market by Application
10.4.6.2.3 Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.4.6.3 U.A.E Angiotensin Converting Enzyme Inhibitors Market
10.4.6.3.1 U.A.E Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.4.6.3.2 U.A.E Angiotensin Converting Enzyme Inhibitors Market by Application
10.4.6.3.3 U.A.E Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market
10.4.6.4.1 Rest of Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.4.6.4.2 Rest of Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market by Application
10.4.6.4.3 Rest of Middle East and Africa Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Angiotensin Converting Enzyme Inhibitors Market Overview
10.5.2 South and Central America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis
10.5.3 South and Central America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Drugs
10.5.4 South and Central America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Application
10.5.5 South and Central America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Angiotensin Converting Enzyme Inhibitors Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Angiotensin Converting Enzyme Inhibitors Market
10.5.6.1.1 Brazil Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.5.6.1.2 Brazil Angiotensin Converting Enzyme Inhibitors Market by Application
10.5.6.1.3 Brazil Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.5.6.2 Argentina Angiotensin Converting Enzyme Inhibitors Market
10.5.6.2.1 Argentina Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.5.6.2.2 Argentina Angiotensin Converting Enzyme Inhibitors Market by Application
10.5.6.2.3 Argentina Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
10.5.6.3 Rest of South and Central America Angiotensin Converting Enzyme Inhibitors Market
10.5.6.3.1 Rest of South and Central America Angiotensin Converting Enzyme Inhibitors Market by Drugs
10.5.6.3.2 Rest of South and Central America Angiotensin Converting Enzyme Inhibitors Market by Application
10.5.6.3.3 Rest of South and Central America Angiotensin Converting Enzyme Inhibitors Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANGIOTENSIN CONVERTING ENZYME INHIBITORS MARKET, KEY COMPANY PROFILES
13.1. PFIZER, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ASTRAZENECA PHARMACEUTICAL COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. NOVARTIS AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DAIICHI SANKYO COMPANY, LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. UNITED THERAPEUTICS CORPORATION
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SANOFI S.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JOHNSON AND JOHNSON SERVICES, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK KGAA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TAKEDA PHARMACEUTICAL COMPANY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BAYER AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer, Inc.
2. AstraZeneca Pharmaceutical Company
3. Novartis AG
4. Daiichi Sankyo Company, Ltd.
5. United Therapeutics Corporation
6. Sanofi S.A.
7. Johnson & Johnson Services, Inc.
8. Merck KGaA
9. Takeda Pharmaceutical Company
10. Bayer AG
TIPRE00023189
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.